skip to Main Content

Dr. Choti on the Role of Upfront Surgery in Pancreatic Adenocarcinoma

Newsfeed image, light gray text on dark gray background
Michael A. Choti, MD, chief of surgery, Banner MD Anderson Cancer Center, discusses the role of upfront surgery in pancreatic adenocarcinoma.

There is some controversy regarding the optimal frontline treatment for patients with pancreatic cancer. There is no debate that patients with elevated CA 19-9, which indicates worse prognosis and increased risk of micrometastatic disease, should receive neoadjuvant chemotherapy. Watch here . . . 

Back To Top